MICOT PHARMA-B (02335.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 21.62

From 52W high−50.43%

Volume850400.00

Market capHKD 6.16B

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataSep 18, 2026

Open

HKD 21.62

From 52W high

−50.43%

Volume

850400.00

Market cap

HKD 6.16B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

P/E (TTM)

—

RSI (14)

27.3

MomentumView details →

1D Return

+1.94%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

—

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

+1.94%

YTD Return

—

1Y Return

—

RSI (14)

27.3

vs 50D SMA

−26.35%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

—

Quick Ratio

—

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Latest newsMore news →

Mackyo Pharmaceuticals announced the completion of Phase II clinical trials for its self-developed candidate drug MT200605, which treats acute ischemic stroke, demonstrating significant efficacy and good safety.25d ago

Micot Medical announced that research results for its main product XTL6001 were accepted for presentation at multiple top international academic conferences in diabetes, metabolic diseases, and kidney diseases, including EASD 2026 and ASN Kidney Week 2026.34d ago

Similar companies

Terns Pharmaceuticals, Inc.TERN Centessa Pharmaceuticals plcCNTA 科前生物688526.SH Oruka Therapeutics, Inc.ORKA Kiniksa Pharmaceuticals, Ltd.KNSA Liquidia CorporationLQDA Find similar companies →

Latest newsMore news →

Mackyo Pharmaceuticals announced the completion of Phase II clinical trials for its self-developed candidate drug MT200605, which treats acute ischemic stroke, demonstrating significant efficacy and good safety.25d ago Micot Medical announced that research results for its main product XTL6001 were accepted for presentation at multiple top international academic conferences in diabetes, metabolic diseases, and kidney diseases, including EASD 2026 and ASN Kidney Week 2026.34d ago